BioMarin Pharmaceutical | BMRN - 流动资产

金融业

USD

USD 7.59B

现金及等价物

USD 1.31B

USD 161.56M

USD 3.95B

USD 759.03M

USD 604.24M

USD 198.39M

USD -24.17M

3.04K

EPS每股收益

USD 0.46

股本和储备

USD 6.09B

USD 713.01M

债务利息支出

USD 2.78M

USD 17.85M

USD 597.18M

USD 10.58B

USD -46.57M

USD 676.18M

USD 198.39M

普通股股本

USD 192.3M

19.24

USD -26.32M

USD 875M

销售和管理费用

USD 322.21M

USD 1.3B

贸易债权人

USD 759.03M

应收帐款人

USD 908.21M

	流动资产	更改		日
Acadia Pharmaceuticals	USD 1.06B		14.31M	2025-12
Agios Pharmaceuticals	USD 942.05M		91.06M	2025-12
Alnylam Pharmaceuticals	USD 4.05B		97.85M	2025-12
Amgen	USD 29.06B		1.17B	2025-12
Bayer	EUR 32.91B		30M	2025-12
Biogen	USD 8.97B		37.5M	2025-12
BioMarin Pharmaceutical	USD 3.95B		98.95M	2025-12
Gilead Sciences	USD 19.89B		1.05B	2025-12
Incyte	USD 5.02B		746.01M	2025-12
Insmed	USD 1.79B		137.6M	2025-12
Ionis Pharmaceuticals	USD 2.99B		471.01M	2025-12
Moderna	USD 6.54B		54M	2025-12
Neurocrine Biosciences	USD 2.52B		364.3M	2025-12
PTC Therapeutics	USD 2.27B		266.14M	2025-12
Puma Biotechnology	USD 143.58M		7M	2025-09
Regeneron Pharmaceuticals	USD 18.02B		41.2M	2025-12
Roche Holding	CHF 38.73B		3.03B	2025-12
Sangamo BioSciences	USD 49.89M		12.3M	2025-06
Sanofi	EUR 30.95B		8.99B	2025-12
Sarepta Therapeutics	USD 2.54B		184.37M	2025-12
Ultragenyx Pharmaceutical	USD 643.21M		76.58M	2025-09
United Therapeutics	USD 3.7B		208.5M	2025-12
Vertex Pharmaceuticals	USD 11.2B		631.4M	2025-12